BIONTECH
LIVE

Serial Number

79263465

Owner

BioNTech SE

Attorney

Monica Riva Talley

Filing Date

Apr 5, 2019

Add to watchlist:

No watchlists yet
View on USPTO

BIONTECH Trademark

Serial Number: 79263465 • Registration: 6066335

BIONTECH is a trademark filed by BioNTech SE on April 5, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BioNTech SE (46 trademarks)

An der Goldgrube 12

Entity Type: 94

Trademark Details

Filing Date

April 5, 2019

Registration Date

June 2, 2020

Published for Opposition

March 17, 2020

Goods & Services

Pharmaceutical and veterinary preparations, namely, preparations for the prevention and treatment of proliferative diseases, cancers, infectious diseases, autoimmune diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; vaccines, namely, DNA-based and RNA-based vaccines, adjuvant preparations for use with vaccines, nucleic acids sequences, proteins, and chemical reagents for medical and veterinary purposes, protein conjugates, peptides featuring antibodies and tumour markers; cell-based immunotherapeutic treatment by way of genetically modified cells, medicated serums for the treatment of proliferating diseases, cancers, infectious diseases, and autoimmune diseases, attenuated viruses and particles similar to viruses, namely, encapsulated nucleic acids; diagnostic reagents and diagnostic preparations for medical purposes

Chemicals used in industry and science, in particular for use in biotechnology, pharmaceutics, medicine and veterinary medicine

Medical services; providing medical care services and consultation related thereto; urgent medical care centers; pharmaceutical and medical consultancy; providing healthcare information and advisory services in the healthcare field; medical consultation services featuring preparation of reports relating to medical and pharmaceutical services; medical and pharmaceutical consultation; all the aforesaid services other than in the field of bione therapy or other types of therapy combined with bione therapy

Scientific research and development in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, in particular research and development in the field of medical and veterinary diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; scientific research and development of diagnostic methods and test processes; scientific research and development related to technical planning and conducting of projects in the field of the supplying of medicines; scientific consultancy services in the field of research and development of therapies and medical preparations; providing of scientific expertise in the nature of scientific study and research in the field of medicine; scientific research and development for medical and veterinary purposes; conducting and evaluating medical and pharmaceutical studies, namely, testing, analysis and evaluation of goods/services of others to determine conformity with certification standards

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 2, 2025 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 24, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 24, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 24, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 24, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 24, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 24, 2025 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 15, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 18, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 28, 2020 FICS
FINAL DISPOSITION PROCESSED
Sep 28, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 2, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 2, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 17, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Mar 13, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 26, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 26, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 26, 2020 NONP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 13, 2020 ADCH
ASSIGNED TO LIE
Feb 11, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 7, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 5, 2020 TROA
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 24, 2019 ADCH
REFUSAL PROCESSED BY IB
Aug 30, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 15, 2019 RFCS
REFUSAL PROCESSED BY MPU
Aug 15, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Jul 26, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 23, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jul 22, 2019 CNRT
ASSIGNED TO EXAMINER
Jul 22, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 22, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 18, 2019 REPR